LicianPro

SION stock

Sionna Therapeutics, Inc. Common Stock (SION) financials · $165.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Sionna Therapeutics, Inc. Common Stock (SION) $165.0M cap.

Annual income statement
LineFY2025FY2024
Operating Income−$88.98M−$70.56M
Net Income−$75.27M−$61.69M
EPS (Diluted)−$1.88−$15.99
Annual balance sheet
LineFY2025
Total Assets$325.95M
Current Assets$241.42M
Cash & Equivalents$58.45M
PP&E$2.23M
Total Liabilities$19.12M
Current Liabilities$11.71M
Shareholders' Equity$306.83M
Retained Earnings−$256.35M
Annual cash flow
LineFY2025FY2024
Operating Cash Flow−$66.30M−$52.79M
CapEx$377.00K$27.00K
Investing Cash Flow−$118.75M−$126.91M
Financing Cash Flow$205.71M$178.97M
Net Change in Cash$20.66M−$733.00K
Free Cash Flow−$66.67M−$52.81M

Source: Company filings with the SEC (EDGAR) · Latest period FY2025

These statements as JSON? API free 100/day

FAQ

What is SION P/E and revenue?

Sionna Therapeutics, Inc. Common Stock (SION) $165.0M cap.

What is SION revenue?

SION income-statement cache has no revenue figure yet.

Is SION profitable?

Sionna Therapeutics, Inc. Common Stock last cached net income is -$75.3M (FY2025).

What are SION total assets?

Sionna Therapeutics, Inc. Common Stock last cached total assets are $326.0M (FY2025).

What is SION free cash flow?

Sionna Therapeutics, Inc. Common Stock last cached free cash flow is -$66.7M (FY2025).

Not investment advice. Figures as reported in company filings, not a live feed.